Followers | 2 |
Posts | 23 |
Boards Moderated | 0 |
Alias Born | 10/19/2023 |
Monday, April 08, 2024 6:25:45 PM
“Determining the "hardest to treat" cancer can be complex because it depends on various factors, including the stage at which the cancer is diagnosed, its type and location, genetic mutations, and how it responds to treatment. However, some cancers are notoriously difficult to treat due to their aggressive nature, tendency to be diagnosed at a late stage, and resistance to current therapies. These include:
1. Pancreatic Cancer: Often diagnosed at a late stage because early-stage pancreatic cancer rarely causes symptoms. It's also known for its resistance to chemotherapy and rapid progression.
2. Glioblastoma (a type of brain cancer): Highly aggressive and known for its poor prognosis. Treatment options are limited because the blood-brain barrier restricts many types of chemotherapy from entering the brain tissue.
3. Lung Cancer: Especially small cell lung cancer, which is aggressive and tends to spread quickly. It's often diagnosed in advanced stages.
4. Liver Cancer: Hepatocellular carcinoma, the most common type of liver cancer, is particularly challenging to treat, especially in cases where the liver is already damaged by diseases such as hepatitis or alcohol abuse.
5. Triple-Negative Breast Cancer: Lacks the three receptors known to fuel most breast cancer growth—estrogen, progesterone, and the HER-2/neu gene—making it resistant to some of the most effective therapies.
These cancers are challenging due to their complexity, aggressiveness, and the body's critical functions they affect, making safe and effective treatment difficult. However, research is ongoing, and advancements in personalized medicine, immunotherapy, and targeted therapy continue to provide hope for better treatments and outcomes.”
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM